Study on the inheritance, innovation and development of Scutellaria baicalensis Georgi in the treatment of COVID-19

ABSTRACT

The discovery of highly effective medicine " Qingfei Paidu Decoction" for COVID-19 is a new era gift of traditional Chinese medicine to the world. The traditional Chinese medicine Scutellaria baicalensis Georgi, as a medicinal plant in the family of Labiatae, is the dominant variety of genuine medicinal material in North China. It is the leading traditional Chinese medicine in the advantageous area of agricultural products with Chinese characteristics in Shangdang of Changzhi City, and it is one of the 21 herbal medicines in the new national prescription " Qingfei Paidu Decoction" for the rapid and effective treatment of COVID-19. This paper introduces S. baicalensis Georgi and its traditional Chinese medicine GAP base, ecologically suitable planting county and medicinal value in poor areas, and studies the intellectual property resources related to S. baicalensis Georgi, such as traditional knowledge, biological genetic resources, patents, new plant varieties, geographical indications, and trademarks. This paper mainly discusses the inheritance essence, innovation and high-quality development strategy of S. baicalensis Georgi under the rural revitalization strategy and traditional Chinese medicine development strategy from the aspects of intellectual property rights, important agricultural cultural heritage, advantageous areas of characteristic agricultural products and so on.